10x Genomics, Inc.
TXG
$26.38
-$0.875-3.21%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.13% | -184.36% | -121.85% | 3.17% | -19.65% |
| Total Depreciation and Amortization | 33.40% | 38.17% | 40.73% | 40.66% | 8.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.23% | 9.87% | 17.32% | 33.76% | 67.62% |
| Change in Net Operating Assets | -5.65% | 188.22% | 262.69% | -503.62% | 52.68% |
| Cash from Operations | -281.21% | 87.70% | -164.58% | 32.05% | 80.17% |
| Capital Expenditure | 36.17% | 91.32% | 58.34% | 6.84% | 83.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.12% | 82.61% | 270.01% | 6,883.77% | 154.27% |
| Cash from Investing | -91.14% | 139.49% | 115.02% | 83.79% | 146.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -7.49% |
| Issuance of Common Stock | -31.75% | 12.24% | 114.52% | 11.57% | -69.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 147.98% | 12.24% | 114.52% | 11.57% | -241.25% |
| Foreign Exchange rate Adjustments | -300.00% | -69.32% | 0.00% | 74.48% | 233.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.12% | 413.77% | 59.95% | 76.67% | 140.75% |
